Cargando…
Rare lymphomas in routine practice—Treatment and outcome in Waldenström's macroglobulinaemia in the prospective German Tumour Registry Lymphatic Neoplasms
Waldenström's macroglobulinaemia (WM) is a rare indolent B‐cell lymphoma for which only little prospective phase III evidence exists. Thus, real world data are important to provide insight into treatment and survival. We present here data on choice and outcome of systemic treatment of patients...
Autores principales: | Knauf, Wolfgang, Abenhardt, Wolfgang, Slawik, Hans Rainer, Bückner, Ute, Otremba, Burkhard, Sauer, Annette, Zahn, Mark‐Oliver, Wetzel, Natalie, Kaiser‐Osterhues, Anja, Houet, Leonora, Marschner, Norbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497085/ https://www.ncbi.nlm.nih.gov/pubmed/32383192 http://dx.doi.org/10.1002/hon.2740 |
Ejemplares similares
-
Rare lymphomas in routine practice – Treatment and outcome in marginal zone lymphoma in the prospective German Tumour Registry Lymphatic Neoplasms
por: Knauf, Wolfgang, et al.
Publicado: (2021) -
Cutaneous Involvement in Waldenström’s Macroglobulinaemia
por: STIEN, Sarah, et al.
Publicado: (2020) -
Waldenström macroglobulinaemia presenting as tingling ulcers on the feet
por: Fischer, Isabelle, et al.
Publicado: (2013) -
Zanubrutinib for mantle cell lymphoma, Waldenström’s macroglobulinaemia
Publicado: (2021) -
Routine treatment of patients with chronic lymphocytic leukaemia by office-based haematologists in Germany—data from the Prospective Tumour Registry Lymphatic Neoplasms†
por: Knauf, Wolfgang, et al.
Publicado: (2015)